Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
BioSpace6h
Evidence Mounts for Benefit of GLP-1s Against Heart Disease
Expanding volumes of data point to mechanisms beyond weight loss and blood sugar control that contribute to cardiovascular ...
Regeneron's Diversified Growth Makes It My Top Biopharma Pick For 2025
Regeneron Pharmaceuticals is a strong investment with robust growth potential, fueled by FDA approvals and resilient market ...
This stick tests your hormones using your phone and saliva
It consists of a thin cartridge that you stick in your mouth for 60 seconds. It looks similar to a pregnancy test, with a ...
SA Asks: Which biotechs are most likely to be acquired near-term?
Last year's first quarter saw a flurry of biotech takeover deals, starting off with Johnson & Johnson (JNJ)/Ambrx, Merck (MRK)/Harpoon, GSK (GSK)/Aiolos and Novartis(NVS)/Calypso in early January.